Age-dependent remodelling of arterial chemoafferent innervation in hypertension
Cardiovascular Research · 2025
DOI: 10.1093/cvr/cvaf207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Audrys G Pauza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Manaaki Mānawa-The Centre for Heart Research, Department of Physiology, Faculty of Medical & Health Sciences, University of Auckland, 85 Park Road, G…. Hauptthemen laut MEDLINE: Hypertension, Carotid Body, Vascular Remodeling, Chemoreceptor Cells. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Foundation of New Zealand, Ernest Hyam Davis & Ted & Mollie Carr Legacies, G.R. Winn Trust.
Abstract (Originalsprache)
Aims
Elevated sympathetic nerve activity (eSNA) is a hallmark of cardiovascular disease and represents an important clinical target for disease management. A known driver of eSNA is aberrant signalling from, and sensitization of, the carotid body (CB) arterial chemoreceptors. Sensitization is coupled with CB hypertrophy, the cause of which remains unclear. Here, we set out to characterize the morphological basis of CB hypertrophy in hypertension to understand its aberrant activity. Methods and results Using high-throughput fluorescence microscopy, we mapped the neurovascular interface and chemoafferent innervation of the CB of spontaneously hypertensive rats (SHR) across multiple age groups. We show that CB hypertrophy driven by chemosensory (type I) cell hyperplasia and an expanded vascular network is evident in 4–6-week-old SHR without established hypertension. Specifically, CB hypertrophy in the SHR is linked to increased chemoafferent innervation and an age-dependent remodelling of nerve fibre composition.
Conclusions
CB hypertrophy in hypertension is associated with chemosensory hyperplasia and angiogenesis, likely mediated by impaired HIF-PHD signalling in the SHR. We propose that CB size may serve as a candidate marker of chemoafferent sensitivity and the efficacy of therapies targeting the CB. However, further validation in humans is needed to support this link. Neurotrophic pathways promoting increased chemoafferent innervation in hypertension are proposed as a potential target for modulating CB activity in sympathetically mediated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Manaaki Mānawa-The Centre for Heart Research, Department of Physiology, Faculty of Medical & Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand.
ORCID-Profile: Audrys G Pauza, Igor Felippe, Xin Shen
Förderung
- National Heart Foundation of New Zealand
- Ernest Hyam Davis & Ted & Mollie Carr Legacies
- G.R. Winn Trust
- Health Research Council of New Zealand
- Sidney Taylor Trust
- Maurice and Phyllis Paykel Trust
Zitieren
APA
Pauza, A. G., Felippe, I., de Laat, I., Gold, O., Shen, X., & Paton, J. F. R. (2025). Age-dependent remodelling of arterial chemoafferent innervation in hypertension. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf207
Vancouver
Pauza AG, Felippe I, de Laat I, Gold O, Shen X, Paton JFR. Age-dependent remodelling of arterial chemoafferent innervation in hypertension. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf207
BibTeX
@article{Pauza2025,
author = {Pauza, Audrys G and Felippe, Igor and de Laat, Iris and Gold, Olivia and Shen, Xin and Paton, Julian F R},
title = {Age-dependent remodelling of arterial chemoafferent innervation in hypertension},
journal = {Cardiovascular Research},
year = {2025},
doi = {10.1093/cvr/cvaf207}
}
EUVIMED